BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31237180)

  • 1. Conceptions within misconceptions: Pluralisms in an Ebola vaccine trial in West Africa.
    Alenichev A; Peeters Grietens K; Gerrets R
    Glob Public Health; 2020 Jan; 15(1):13-21. PubMed ID: 31237180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ebola vaccine, therapeutics, and diagnostics].
    Furuyama W; Takada A
    Uirusu; 2016; 66(1):63-72. PubMed ID: 28484180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics, emergencies and Ebola clinical trials: the role of governments and communities in offshored research.
    Folayan MO; Peterson K; Kombe F
    Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):10. PubMed ID: 26740838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical considerations in the conduct of research on therapies for the prevention and treatment of Ebola virus disease in developing countries.
    Folayan MO; Haire BG
    Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):8. PubMed ID: 26740837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine trial launched to stop Ebola.
    Cohen J
    Science; 2018 May; 360(6390):694-695. PubMed ID: 29773723
    [No Abstract]   [Full Text] [Related]  

  • 6. [Overview of the Ebola vaccines in pre-clinical and clinical development].
    Buchy P
    Bull Soc Pathol Exot; 2016 Oct; 109(4):256-261. PubMed ID: 27646961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.
    Higgs ES; Dubey SA; Coller BAG; Simon JK; Bollinger L; Sorenson RA; Wilson B; Nason MC; Hensley LE
    Curr Top Microbiol Immunol; 2017; 411():229-261. PubMed ID: 28918539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
    Lhomme E; Modet C; Augier A; Faye S; Dabakuyo-Yonli TS; Levy-Marchal C; D'Ortenzio E; Yazdanpanah Y; ChĂȘne G; Beavogui AH; Richert L;
    Trials; 2019 Jul; 20(1):422. PubMed ID: 31296253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us.
    Varkey JB; Ribner BS
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical allocation of drugs and vaccines in the West African ebola epidemic.
    Gostin LO
    Milbank Q; 2014 Dec; 92(4):662-6. PubMed ID: 25492601
    [No Abstract]   [Full Text] [Related]  

  • 11. On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.
    Henao-Restrepo AM; Preziosi MP; Wood D; Moorthy V; Kieny MP;
    Curr Opin Virol; 2016 Apr; 17():138-144. PubMed ID: 27180074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethics of Conducting Clinical Research in an Outbreak Setting.
    Edwards KM; Kochhar S
    Annu Rev Virol; 2020 Sep; 7(1):475-494. PubMed ID: 32212920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola R&D woes spur action.
    Check Hayden E
    Nature; 2015 May; 521(7553):405-6. PubMed ID: 26017422
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials of Ebola vaccine must continue despite fall in number of cases.
    Gulland A
    BMJ; 2015 Feb; 350():h944. PubMed ID: 25691506
    [No Abstract]   [Full Text] [Related]  

  • 15. Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone.
    Enria L; Lees S; Smout E; Mooney T; Tengbeh AF; Leigh B; Greenwood B; Watson-Jones D; Larson H
    BMC Public Health; 2016 Nov; 16(1):1140. PubMed ID: 27821112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency.
    Larson GS; Baseler BR; Hoover ML; Pierson JF; Tegli JK; Johnson MP; Kieh MWS; McNay LA; Njoh WS
    Am J Trop Med Hyg; 2017 Jul; 97(1):10-15. PubMed ID: 28719299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholders' engagement with Ebola therapy research in resource limited settings.
    Folayan MO; Brown B; Haire B; Yakubu A; Peterson K; Tegli J
    BMC Infect Dis; 2015 Jun; 15():242. PubMed ID: 26113124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible roles of endogenous RNA virus elements in RNA virus infection].
    Komiya N
    Uirusu; 2016; 66(1):47-52. PubMed ID: 28484178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola Virus Diseases in Africa: a commentary on its history, local and global context.
    Awah PK; Boock AU; Kum KA
    Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):18. PubMed ID: 26740846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola vaccine development plan: ethics, concerns and proposed measures.
    Folayan MO; Yakubu A; Haire B; Peterson K
    BMC Med Ethics; 2016 Feb; 17():10. PubMed ID: 26857351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.